Submitted by Chahin Pachai on October 28, 2013Next month, I will be attending the 6th annual Clinical Trials Conference on Alzheimer’s Disease (CTAD) conference along with fellow members of the BioClinica Central Nervous System therapeutic team including Luc Bracoud, Joël Schaerer and Florent Roche.
- Longitudinal whole brain, ventricular and hippocampal atrophy rates of the CN156-018 cohort compared with ADNI-1.
- Comparison of Tensor Based Morphometry (TBM) and Boundary Shift Integral (BSI) for assessing whole brain, ventricular atrophy.
- Predictive value of baseline hippocampal volume and brain amyloid burden on atrophy rates for predementia AD subjects.
- 2D and 3D image quantification strategies for assessing intracranial volume using MRI.
The volumetric MRI results from this study were obtained by applying BioClinica’s fully-automated image processing and quantification methods.
Link to original post: http://www.bioclinica.com/blog/important-alzheimer’s-research-display-ctad-2013